US Stock MarketDetailed Quotes

CDT Conduit Pharmaceuticals

Watchlist
  • 0.138
  • +0.008+5.93%
Trading Sep 17 12:43 ET
13.20MMarket Cap-1676P/E (TTM)

Conduit Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
138.78%3.14M
95.05%2.96M
66.52%5.26M
-46.54%895K
14.58%1.07M
1.32M
420.62%1.52M
-0.41%3.16M
1.67M
933K
Selling and administrative expenses
136.88%3.12M
86.60%2.83M
69.63%5.17M
-53.22%805K
37.94%1.07M
--1.32M
420.62%1.52M
5.50%3.05M
--1.72M
--775K
-General and administrative expense
136.88%3.12M
86.60%2.83M
69.63%5.17M
-53.22%805K
37.94%1.07M
--1.32M
420.62%1.52M
5.50%3.05M
--1.72M
--775K
Research and development costs
--25K
--128K
-18.92%90K
291.49%90K
--0
--0
--0
-60.78%111K
---47K
--158K
Operating profit
-138.78%-3.14M
-95.05%-2.96M
-66.52%-5.26M
46.54%-895K
-14.58%-1.07M
-1.32M
-420.62%-1.52M
0.41%-3.16M
-1.67M
-933K
Net non-operating interest income expense
-117K
-110K
-392K
-300K
-47K
0
0
0
0
0
Non-operating interest income
--2K
--9K
--30K
----
----
--0
--0
--0
----
----
Non-operating interest expense
--119K
--119K
--422K
--330K
--47K
--0
--0
--0
--0
--0
Other net income (expense)
-183.09%-2.13M
-210.19%-487K
396.41%5.12M
312.88%2.97M
13,586.96%3.1M
-751K
-881.25%-157K
-256.82%-1.73M
-1.4M
-23K
Gain on sale of security
111.54%84K
----
458.00%5.23M
----
----
---728K
----
-255.72%-1.46M
----
----
Other non- operating income (expenses)
-9,508.70%-2.21M
-210.19%-487K
56.60%-115K
-3,576.92%-2.26M
13,586.96%3.1M
---23K
-15,600.00%-157K
-263.01%-265K
--65K
---23K
Income before tax
-160.55%-5.38M
-112.44%-3.55M
89.05%-535K
157.93%1.78M
307.74%1.99M
-2.07M
-444.63%-1.67M
-33.63%-4.89M
-3.07M
-956K
Income tax
Net income
-160.55%-5.38M
-112.44%-3.55M
89.05%-535K
157.93%1.78M
307.74%1.99M
-2.07M
-444.63%-1.67M
-33.63%-4.89M
-3.07M
-956K
Net income continuous Operations
-160.55%-5.38M
-112.44%-3.55M
89.05%-535K
157.93%1.78M
307.74%1.99M
---2.07M
-444.63%-1.67M
-33.63%-4.89M
---3.07M
---956K
Minority interest income
Net income attributable to the parent company
-155.60%-5.38M
-112.44%-3.55M
89.05%-535K
157.93%1.78M
307.74%1.99M
-2.11M
-444.63%-1.67M
-33.63%-4.89M
-3.07M
-956K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-155.60%-5.38M
-112.44%-3.55M
89.05%-535K
157.93%1.78M
307.74%1.99M
-2.11M
-444.63%-1.67M
-33.63%-4.89M
-3.07M
-956K
Basic earnings per share
-140.71%-0.07
-116.56%-0.05
85.18%-0.01
170.74%0.03
327.26%0.03
-0.0291
-444.66%-0.0231
-33.63%-0.0675
-0.0424
-0.0132
Diluted earnings per share
-140.71%-0.07
-116.56%-0.05
-33.37%-0.09
52.84%-0.02
327.26%0.03
-0.0291
-444.66%-0.0231
-33.63%-0.0675
-0.0424
-0.0132
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 138.78%3.14M95.05%2.96M66.52%5.26M-46.54%895K14.58%1.07M1.32M420.62%1.52M-0.41%3.16M1.67M933K
Selling and administrative expenses 136.88%3.12M86.60%2.83M69.63%5.17M-53.22%805K37.94%1.07M--1.32M420.62%1.52M5.50%3.05M--1.72M--775K
-General and administrative expense 136.88%3.12M86.60%2.83M69.63%5.17M-53.22%805K37.94%1.07M--1.32M420.62%1.52M5.50%3.05M--1.72M--775K
Research and development costs --25K--128K-18.92%90K291.49%90K--0--0--0-60.78%111K---47K--158K
Operating profit -138.78%-3.14M-95.05%-2.96M-66.52%-5.26M46.54%-895K-14.58%-1.07M-1.32M-420.62%-1.52M0.41%-3.16M-1.67M-933K
Net non-operating interest income expense -117K-110K-392K-300K-47K00000
Non-operating interest income --2K--9K--30K----------0--0--0--------
Non-operating interest expense --119K--119K--422K--330K--47K--0--0--0--0--0
Other net income (expense) -183.09%-2.13M-210.19%-487K396.41%5.12M312.88%2.97M13,586.96%3.1M-751K-881.25%-157K-256.82%-1.73M-1.4M-23K
Gain on sale of security 111.54%84K----458.00%5.23M-----------728K-----255.72%-1.46M--------
Other non- operating income (expenses) -9,508.70%-2.21M-210.19%-487K56.60%-115K-3,576.92%-2.26M13,586.96%3.1M---23K-15,600.00%-157K-263.01%-265K--65K---23K
Income before tax -160.55%-5.38M-112.44%-3.55M89.05%-535K157.93%1.78M307.74%1.99M-2.07M-444.63%-1.67M-33.63%-4.89M-3.07M-956K
Income tax
Net income -160.55%-5.38M-112.44%-3.55M89.05%-535K157.93%1.78M307.74%1.99M-2.07M-444.63%-1.67M-33.63%-4.89M-3.07M-956K
Net income continuous Operations -160.55%-5.38M-112.44%-3.55M89.05%-535K157.93%1.78M307.74%1.99M---2.07M-444.63%-1.67M-33.63%-4.89M---3.07M---956K
Minority interest income
Net income attributable to the parent company -155.60%-5.38M-112.44%-3.55M89.05%-535K157.93%1.78M307.74%1.99M-2.11M-444.63%-1.67M-33.63%-4.89M-3.07M-956K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -155.60%-5.38M-112.44%-3.55M89.05%-535K157.93%1.78M307.74%1.99M-2.11M-444.63%-1.67M-33.63%-4.89M-3.07M-956K
Basic earnings per share -140.71%-0.07-116.56%-0.0585.18%-0.01170.74%0.03327.26%0.03-0.0291-444.66%-0.0231-33.63%-0.0675-0.0424-0.0132
Diluted earnings per share -140.71%-0.07-116.56%-0.05-33.37%-0.0952.84%-0.02327.26%0.03-0.0291-444.66%-0.0231-33.63%-0.0675-0.0424-0.0132
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data